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Abstract
Objective To study the relation between self reported
stressful life events not related to multiple sclerosis
and the occurrence of exacerbations in
relapsing-remitting multiple sclerosis.
Design Longitudinal, prospective cohort study.
Setting Outpatient clinic of department of neurology
in the Netherlands.
Participants Patients aged 18-55 with
relapsing-remitting multiple sclerosis, who could walk
with a cane or better (score of 0-6.0 on the expanded
disability status scale), and had had at least two
exacerbations in 24 months before inclusion in the
study. Patients with other serious conditions were
excluded.
Main outcome measure The risk of increased disease
activity as measured by the occurrence of
exacerbations after weeks with stressful events.
Results Seventy out of 73 included patients (96%)
reported at least one stressful event. In total, 457
stressful life events were reported that were not
related to multiple sclerosis. Average follow up time
was 1.4 years. Throughout the study, 134
exacerbations occurred in 56 patients and 136
infections occurred in 57 patients. Cox regression
analysis with time dependent variables showed that
stress was associated with a doubling of the
exacerbation rate (relative risk 2.2, 95% confidence
interval 1.2 to 4.0, P = 0.014) during the subsequent
four weeks. Infections were associated with a threefold
increase in the risk of exacerbation, but this effect was
found to be independent of experienced stress.
Conclusion Stressful events were associated with
increased exacerbations in relapsing-remitting
multiple sclerosis. This association was independent of
the triggering effect of infections on exacerbations of
multiple sclerosis.
Introduction
Multiple sclerosis is a chronic progressive disease that is
characterised by a course of exacerbations and
remissions in 85-90% of patients. Exacerbations are a
clinical reflection of increased inflammatory activity in
the central nervous system.1 2 They occur in an
unpredictable fashion, but the consensus is that they are
mediated through immunological mechanisms. Precipi-
tating factors that have been identified are infections (of
the upper respiratory tract) and the early postpartum
period.3–5 Psychological stress is an additional factor that
has been implicated repeatedly as a determinant of
disease activity ever since Charcot first described the
disease.6–13 The biological rationale for such an effect is
that psychological stress can modulate immunological
mechanisms via the hypothalamic-pituitary-adrenal axis
and the sympathetic nervous system.14 15 However,
evidence on the relation between psychological stress
and exacerbations of multiple sclerosis is limited, partly
because of the design of previous studies and the lack of
agreement about the definition of stress. The recent
report of the American Academy of Neurology about
the relation between stress and exacerbations of
multiple sclerosis stressed the need to obtain tightly
defined prospective data.16 We assessed in a prospective
cohort setting whether life events that are perceived as
stressful by patients themselves are associated with
exacerbations in relapsing-remitting multiple sclerosis.
Moreover, we investigated whether stressful events and
infections are independently associated factors.
Patients and methods
This study was part of the Rotterdam study on exacer-
bations that was conducted as a single centre study
between July 1997 and December 1999.4 Included
were patients aged 15-55 who had clinically definite
multiple sclerosis with a relapsing-remitting course. All
patients gave written consent before participating in
the study.
Study design
We collected clinical data prospectively during regular
and additional visits at the outpatient clinic. Regular
visits were scheduled every eight weeks. Additional
visits were arranged within three days after patients
reported symptoms of either infection or exacerbation.
Each of these additional visits was followed by a control
visit three weeks later. Neurological examination was
performed at every regular and additional visit, and the
same investigator (DB) scored the expanded disability
status scale. Every Sunday during follow up patients
assessed stressful events in self reported weekly diaries.
Patients were asked whether they had experienced an
emotionally stressful event in the preceding week. If
they had they were asked to describe the event in their
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own words. The diaries were collected at each regular
visit. Two neurologists (DB and RQH) independently
evaluated whether the reported stressful events were
directly connected to existing signs or symptoms of
multiple sclerosis, to exclude stress caused by multiple
sclerosis itself.
This was done blinded for the time point that the
event was noted. Any differences were discussed with a
third investigator (PAvD), until a final evaluation was
reached by consensus.
An exacerbation was defined as a worsening of
existing symptoms or appearance of new symptoms,
lasting more than 24 hours and after at least 30 days of
improvement or stability.17 Patients reported suspected
exacerbations, which were then confirmed at addi-
tional visits. Neurological deterioration only temporar-
ily associated with a period of fever was not considered
as an exacerbation. Infection was defined as the
appearance of coryza, sore throat, flu-like feeling,
myalgia, fever, diarrhoea, or a urinary infection lasting
for more than 24 hours.
Statistical analysis
Mohr et al thought that increased stress affects inflam-
matory lesions observed on magnetic resonance imag-
ing within a few weeks.18 Other known precipitating
factors of disease activity of multiple sclerosis act
within several weeks. For example, infections increase
the risk of exacerbation until five weeks after onset,3
and the effect of the early postpartum period can be
observed within four weeks after delivery.5 We
therefore chose a window of four weeks to study the
association between stress and exacerbations.
After each stressful event patients were considered
to enter a period of four weeks with high risk of an
exacerbation. (For example, if a patient reported stress-
ful events during the 20th, 30th, and 33rd week of fol-
low up, the first high risk period ranged from week 21
to week 24. The second high risk period for this patient
started in week 31 and lasted until week 37 because of
the extension of the period by the event at week 33.)
To assess the predictive value of the periods of high
risk, at each point in time during follow up we
compared the exacerbation rates of patients at high
risk and patients not at high risk. We used Cox
regression with time dependent variables separately
for the first, second, and third exacerbation.19 In analys-
ing the second and third exacerbation we considered
the time axis to originate at the time of the previous
exacerbation. In relation to infections we defined
another (time dependent) period at risk, which
extended from two weeks before the onset of an infec-
tion until five weeks thereafter.3 4 We used multivariate
Cox regression to evaluate simultaneously the associa-
tions of the high risk period due to stressful events and
due to infections. We included appropriate interaction
terms to evaluate whether or not both factors were
independently associated with the exacerbation rate.
We used Logxact (Cytel Software Corporation,
Cambridge, MA, USA) for calculations for this particu-
lar analysis. Results are expressed as relative exacerba-
tion rates, and P = 0.05 (two sided) was considered the
level of significance.
Results
Patients and reported stressful life events
We identified 110 patients as eligible for inclusion.
Owing to the intense schedule of the study, 37 patients
chose not to take part. Table 1 shows baseline
characteristics of the participating patients. Seventy out
of the 73 included patients (96%) reported at least one
stressful event. Average follow up time for the study
group was 74 weeks (median 88, range 8-120) or 1.4
years. Thirteen patients dropped out before the end of
the study, but they still participated for a median of 32
weeks (mean 46, range 8-112) per individual.
We found no relation between the cumulative
number of reported stressful events and the probability
of dropping out of the study. In total we analysed 124
patient years. The diaries that had been completed
properly covered 84% (5416/6466) of all weeks of the
total follow up time, and these were all included in the
analysis. In total 505 stressful life events were reported.
Forty eight events were directly related to signs or
symptoms of multiple sclerosis and were excluded,
which left 457 events for analysis. Table 2 shows a cat-
egorisation of the events. The average duration of a
stressful event as noted in the diaries was 2.8 weeks. We
assessed mental health at entry into the study by men-
tal health subscores of the quality of life scale of the
short form questionnaire (SF-36). The average score
was 68.6 (SD 17.4), which was comparable with the
scores that we observed in an independent study
population of 101 patients with relapsing-remitting
multiple sclerosis.20 Overall, 134 exacerbations
occurred in 56/73 patients—an average of 1.3
exacerbations per year. Altogether 136 episodes of
infections were seen in 57 patients—an average of 1.3
infections per year.
Stressful events and the risk of exacerbation
For each week of the study we grouped patients
according to whether or not they had experienced
Table 1 Baseline characteristics of 16 male and 56 female
patients with multiple sclerosis who were included in the study.
Values are means (medians, ranges) unless otherwise specified
Characteristic Value
Mean age (years) 39.9 (median 40, range 19-55)
Duration of disease (years since diagnosis) 5.2 (median 4, range 1-25)
Expanded disability status score at baseline 2.6 (median 2.0, range 0-6.0)
Diaries completed (weeks) 5416*
No of exacerbations 134
No of infections 136
*84% of total follow up.
Table 2 Categories of reported stressful events
Event No of times reported (n=457)
Illness or problems with close family member 107
Job stress 54
Events related to house or car (repair, theft, etc) 52
Sudden personal discomfort, not related to multiple sclerosis* 52
Death of distant relative or friend 35
Financial problems 31
Death of close family member 29
Illness or problems with distant relative or friend 28
Illness or death of pet 27
Problems in relationship or marriage 24
Stress related to holiday 18
*Encompasses pain (gastric, dental, headache), physical trauma, minor surgery, and occurrence of sudden
negative emotions.
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stress in the four weeks immediately preceding it.
Figure 1 shows the prevalence of stress for patients at
risk of a first exacerbation in relation to the week of the
study, and also shows the presence of stress in the pre-
ceding four weeks for individual patients with an exac-
erbation (n = 55). It shows that, although the preva-
lence of self reported stressful events remains more or
less constant at about 50%, most patients (40/55) with
an exacerbation had experienced stress during the
four preceding weeks (one exacerbation occurring in
week 1 could not be evaluated for stress in preceding
weeks and was excluded from the analysis).
Figure 2 (left panel) shows the cumulated risks for
exacerbation according to whether (curve A) or not
(curve B) stress has been present in the four preceding
weeks. The right panel shows the cumulated risk, but
now after a first exacerbation had occurred. From the
curves (log scaling) it can be concluded that the risk for
occurrence of exacerbation associated with a four week
period with one stressful event in it was about double
after four weeks without reported stress. Cox univariate
regression showed that a stressful event is associated
with 2.2 times (95% confidence interval 1.2 to 4.0,
P = 0.012) the rate of exacerbation during the
following four weeks. The same analysis for the second
exacerbation gave similar results (fig 2, right panel).
The risk for the second exacerbation was increased 2.7
times (1.2 to 5.9, P = 0.015) after a four week period
with one stressful event. We found no significantly
increased risk in relation to stress for third exacerba-
tions (relative risk 1.2, P = 0.62), but the 95%
confidence interval was wide (0.5 to 3.0).
We compared the risk of exacerbation after four
weeks with a single reported stressful event with that of
four weeks with multiple reported stress events and
found no significant differences. This indicates that the
effect of stress on exacerbations is not “dose dependent.”
Infections, stressful events, and exacerbations
Infections are associated with an increased risk of
exacerbations of multiple sclerosis.3 4 Table 3 shows the
results of a simultaneous evaluation by using multivari-
ate Cox regression of both reported stress and the
presence of an increased risk of exacerbation around
the time of clinical infection (“at risk period”). For the
first two exacerbations, both evaluated factors were sig-
nificant risk factors, whereas for the third exacerbation
only the presence of infections was significantly related
to this outcome.
Further analysis showed that both risk factors did
not significantly depend on each other. The fact that
these two factors were independently associated with the
course of the disease implies that the risk for the onset of
the first exacerbation in patients with both of these
factors is increased up to 6.4 times (2.2×2.9) compared
with patients in whom both factors are absent.
Discussion
In patients with multiple sclerosis the experience of at
least one stressful event during a period of four weeks
was associated with double the risk of an exacerbation
within the next week.
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Fig 1 Presence of reported stress during the time window of four
weeks before the first exacerbation.
Table 3 Multivariate analysis of the risk of occurrence of exacerbation with respect to the presence of stress and infection
No of exacerbations/No of weeks of follow up
Exacerbation Risk factor Relative risk (95% CI) At high risk At low risk P value
First (n=55) Stress* 2.2 (1.2 to 4.0) 40/1143 15/984 0.014
Infection** 2.9 (1.6 to 5.1) 20/365 36/1866 <0.001
Second (n=32) Stress 2.7 (1.2 to 6.0) 20/762 12/1130 0.015
Infection 2.7 (1.1 to 6.3) 8/253 24/1705 0.023
Third (n=23) Stress 1.0 (0.4 to 2.5) 12/337 10/352 0.99
Infection 3.2 (1.3 to 8.1) 9/157 14/568 0.014
Owing to missing diary data weeks could occasionally not be classified for stress (high or low risk). The number of weeks is therefore not always the same for both
risk factors (stress and infection).
*Reported at least once during the preceding four weeks.
**Week is part of period at risk for infection. Each time a stressful event occurs a period with high risk starts that lasts four weeks. With respect to infections, a
period with high risk starts two weeks before the onset of an infection and ends five weeks after the infection. Relative risk represents the relative risk of an
exacerbation during these high risk periods.
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Relation to previous studies
An association between stressful life events and disease
activity in multiple sclerosis has been assumed for a
long time,7–14 although negative findings have been
reported.21 Several methodological difficulties16 have
hampered a clear conclusion on this issue.7–13 22 For
example, most studies had a retrospective design that
probably introduced recall bias. In the available studies,
exacerbations were often not confirmed, and the inter-
vals for recording of stress or stress events were within
the range of months to even years. In our study, stress-
ful life events were reported weekly by patients
themselves and recorded in a prospective fashion.
Patients were seen at regular survey visits at close inter-
vals, and additional visits were arranged in cases of
infection or exacerbation.4 All relapses were confirmed
by neurological examination by a doctor. We focused
on either the mere presence or absence of personal
experience of a stressful event as we judged this the
most practical approach to analyse the external stress
that a patient faces during daily life. We made
maximum efforts to exclude interference by situations
of stress directly originating from the symptoms of the
disease itself. Internal robustness of the results is found
in the fact that increased risks were also observed for a
second exacerbation. This significance was lost for a
third exacerbation, possibly because of the small num-
bers; the resulting confidence interval is very wide.One
study analysed the relation between stress and disease
activity by using a surrogate marker instead of clinical
exacerbations.18 Mohr et al showed increased odds of
developing new gadolinium enhancing lesions in the
weeks after moderately stressful life events. They found,
however, no relation between the stress events and
clinical exacerbations, which were stringently defined
as changes of 1.0 point or more on the expanded dis-
ability status scale. An important difference to our
study is that we used the criteria of Schumacher et
al—new or worsening symptoms associated with a con-
firmatory change lasting more than 24 hours, in the
absence of fever.17
For the analysis, on a priori grounds,3 5 18 we had
chosen a period with increased risk of four weeks after
a stressful event. To investigate the sensitivity of our
findings with respect to this choice, we also analysed
the exacerbation rates for some other time windows.
When we repeated the analysis with respective
windows of two, three, and five weeks, only the window
of three weeks showed a significantly increased risk of
exacerbation (relative risk 2.1, P = 0.012). We obtained
similar results when considering these windows before
a second exacerbation. We did not, however, record
whether the events took place at the beginning, the
middle, or the end of the week. Therefore the period of
increased risk is probably three to five weeks.
Limitations of this study
We collected participants’ diaries every eight weeks.
Although this included frequent contact with patients
and extensive control for compliance,the diaries may
not have been filled immediately after an event
happened but rather, for example, just before regular
appointments or around major events. However, we
found no indication for reporting around such biased
time points as no increased stress in relation to
infections was reported in the week of the relapse itself
nor just before the regular eight week visits. Even if this
had been the case it would have resulted in an under-
estimation of the stress during the four weeks preced-
ing exacerbations.
Furthermore, we relied on a single item, self
reported stress scale instead of using a validated multi-
item instrument. Our stress scale assessed the
perceived presence or absence of psychological stress
but provided no information on the intensity of stress
and did not use a normative definition of stressful
events. We anticipated that compliance in the frequent
and prospective data sampling would be maintained by
the use of a single item rather than a multi-item stress
scale. Such an approach is similar to previous studies
on infections and exacerbations that also analysed the
mere occurrence of infections rather than taking into
account the severity or exact character of infection.3 4
An important difference to other studies7–13 16 21 22 is our
emphasis on self report of exposure to stress events as
well as the frequent and prospective sampling.
Possible mechanisms
The mechanism behind increased stress and the
induction of inflammatory disease activity in an
autoimmune disease such as multiple sclerosis is not
yet fully understood. Modulation of both the
hypothalamic-pituitary-adrenal axis and the sympa-
thetic system can have a notable effect on lymphocyte
dependent inflammatory reactions, at least partly by
modulation of cytokine production and lymphocyte
expressed adrenergic receptors.14 15 23 24 In future
clinical studies on this issue it would be of interest to
measure neuroendocrine variables in blood samples,
such as adrenaline, cortisol, and lymphocyte expres-
sion of neuroendocrine receptors. This could also
serve as an objective biological measure of stress. How-
ever, for such a study it would be necessary to obtain
blood samples frequently.
Stress and infection and the risk of an exacerbation
Certain types of psychological stress can suppress
immune reactions, and this could lead to increased
susceptibility to infections.25 Therefore our observed
association of stressful events with exacerbations of
multiple sclerosis might simply be linked to an increase
of infections after stressful events in our patients. How-
What is already known on this topic
Psychological stress has been implicated as a
determinant of disease activity in multiple sclerosis
Evidence on the relation between stressful events
and exacerbations of multiple sclerosis is lacking
A recent report of the American Academy of
Neurology emphasised the need to obtain tightly
defined prospective data
What this study adds
Patients with multiple sclerosis who experience a
stressful event are subsequently at increased risk of
an exacerbation of their disease
Stress and infection are independently associated
with the risk of an exacerbation
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ever, we found no evidence for an increase of infections
after stressful life events. Stress and infection were
independently associated with the risk of exacerbation.
It will not be easy to tackle these factors in a given
patient, because both infections and stressful events
cannot simply be eradicated from patients’ lives. The
knowledge that stressful events are associated with dis-
ease activity adds important information to the limited
insight that patients and their caregivers have on this
unpredictable disease.
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